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This volume consists of twelve papers on the chemistry, experimental
and clinical pharmacology, and the clinical applications of the Rauwolfia
alkaloids presented at a conference on Reserpine (Serpasil), sponsored by
the Section of Biology of The New York Academy of Sciences on Febru-
ary 5, 1954. These alkaloids, which apparently have been used for centuries
by Indian physicians, are now stimulating a great deal of interest and
research in the Western world with at least two objectives: application in
the treatment of hypertension and possible usefulness in certain neuro-
psychiatric disorders.
The chemical structure of one active principle, called Reserpine, has been
elegantly elucidated by chemists of the Ciba Company and is reminiscent of
a well-known alkaloid, yohimbine, which elicits bizarre effects from the
central nervous system. This paper is one of the most impressive in the
volume.
In the hands of the experimental pharmacologist the compound seems to
exert a variety of autonomic effects, referable to decreased predominance of
the sympathetic branch. It is suggested in two of the papers that the site of
action is probably the hypothalamus where autonomic functions are in-
tegrated. However, no direct evidence for this hypothesis is presented,
except, perhaps, in the paper by Travis Winsor, who was able to block
inspiratory and pain reflexes after large doses of the drug.
The clinical work presented here is provocative but, like all early clinical
reports, needs to be evaluated in the light of wider experience. If one recog-
nizes that the therapy of essential hypertension still remains empirical, then
one may accept the concensus presented here that Reserpine may become
the agent of choice in the chemotherapy of less severe essential hypertension,
especially in combination with other hypotensive agents like hydralazine,
veratrum alkaloids, hexamethonium, etc. One clinical point emerges as
fairly definite, and that is that Reserpine presents no serious side effects in
contrast to most other currently available hypotensive agents.
The contention in the paper by R. W. Wilkins that the slow onset of
action of Reserpine is due to a part played in intermediary processes of the
central nervous system seems somewhat premature, in view of the fact that
no knowledge of the metabolic fate and distribution of the drug is yet
available.
In the studies of the effect of Reserpine on various neuropsychiatric
patients, a significant tranquilizing effect and alterations of psychic states
were noted. These results are, indeed, intriguing, and, as N. S. Kline has
pointed out, are indicative of the "need for long-term, large-scale evaluation
of this medication."
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